Pegcetacoplan Shows Mixed Results for Geographic Atrophy

by Medscape • 2021/09/17 • 0 Comments

Two phase 3 trials yielded different results for pegcetacoplan as a treatment for geographic atrophy.
Medscape Medical News

← Global Eye Care Surgical Devices Market 2021-2025: High Incidence of Eye Diseases and growing Number of MI Glaucoma Surgeries Driving Growth – ResearchAndMarkets.com

Optic Neuritis (Ophthalmology) Drugs Pipeline Guide 2021 – ResearchAndMarkets.com →